{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:13Z","timestamp":1767135253109,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012514","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000}}],"reference-count":48,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012514.pub2","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:11:20Z","timestamp":1528715480000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dual antibiotics for bronchiectasis"],"prefix":"10.1002","volume":"2018","author":[{"given":"Lambert M","family":"Felix","sequence":"first","affiliation":[{"name":"University of Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seamus","family":"Grundy","sequence":"additional","affiliation":[{"name":"Aintree University Hospital; Department of Thoracic Medicine; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Milan","sequence":"additional","affiliation":[{"name":"Lancaster University; Medical School; Lancaster UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Edge Hill University; Sport and Physical Activity; Ormskirk UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Harrison","sequence":"additional","affiliation":[{"name":"Southport and Ormskirk Hospital NHS Trust; Southport UK PR8 6PN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Lynes","sequence":"additional","affiliation":[{"name":"Edge Hill University; Faculty of Health and Social Care; Ormskirk UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Spencer","sequence":"additional","affiliation":[{"name":"Edge Hill University; Postgraduate Medical Institute; St Helens Road Ormskirk Lancashire UK L39 4QP"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012514.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012514.pub2-BIB0002|cit2","first-page":"38 (OS 08-01)","article-title":"Change in clinical outcome of exacerbation of bronchiectasis on addition of nebulized gentamicin to systemic antibiotic","volume":"15","author":"Hossain","year":"2010","journal-title":"Respirology"},{"issue":"7","key":"10.1002\/14651858.CD012514.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012514.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000438490","article-title":"Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"90","author":"Orriols","year":"2015","journal-title":"Respiration"},{"issue":"9","key":"10.1002\/14651858.CD012514.pub2-BIB0005|cit5","first-page":"1131","article-title":"Imipenem\/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections","volume":"47","author":"Takamoto","year":"1994","journal-title":"Japanese Journal of Antibiotics"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0006|cit6","first-page":"205","article-title":"[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology]","volume":"41","author":"Vergnon","year":"1985","journal-title":"Revue de Pneumologie Clinique"},{"issue":"10","key":"10.1002\/14651858.CD012514.pub2-BIB0007|cit7","first-page":"1194","article-title":"A well-controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin for the treatment of repeated acute exacerbations of chronic respiratory tract infections","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD012514.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012514.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index: an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012514.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.2002.tb04733.x","article-title":"Bronchiectasis in indigenous children in remote Australian communities","volume":"177","author":"Chang","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"6","key":"10.1002\/14651858.CD012514.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0012|cit12","first-page":"6","article-title":"Inflammation: a two-edged sword - the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"European Journal of Respiratory Diseases Supplement"},{"issue":"Suppl A","key":"10.1002\/14651858.CD012514.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/40.suppl_1.5","article-title":"The damaging role of bacteria in chronic lung infection","volume":"40","author":"Cole","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD012514.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002007.pub2","article-title":"Single versus combination intravenous antibiotic therapy for people with cystic fibrosis","author":"Elphick","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0015|cit15","unstructured":"Gibson GJ Loddenkemper R Sibille Y Lundb\u00e4ck B editor(s) European Lung White Book: Respiratory Health and Disease in Europe www.erswhitebook.org\/"},{"issue":"8","key":"10.1002\/14651858.CD012514.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of P seudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD012514.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0954-6111(03)00063-5","article-title":"Long-term antibiotics in the management of non-CF bronchiectasis - do they improve outcome?","volume":"97","author":"Evans","year":"2003","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0018|cit18","first-page":"68","article-title":"Microbiology of non-CF bronchiectasis","volume":"52","author":"Foweraker","year":"2011","journal-title":"European Respiratory Society Monograph"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0019|cit19","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1817-1737.82443","article-title":"Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis","volume":"6","author":"Habesoglu","year":"2011","journal-title":"Annals of Thoracic Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012514.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011825","article-title":"Adverse events in patients taking macrolide antibiotics versus placebo for any indication","author":"Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"975-82","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0023|cit23","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012590","article-title":"Head-to-head trials of antibiotics for non-cystic fibrosis bronchiectasis","author":"Kaehne","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"300-7","DOI":"10.1002\/ppul.21550","article-title":"Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis","volume":"47","author":"Kapur","year":"2012","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD012514.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.11-0679","article-title":"The burden of disease in pediatric non-cystic fibrosis bronchiectasis","volume":"141","author":"Kapur","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012406.pub2","article-title":"Macrolide antibiotics for bronchiectasis","author":"Kelly","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0028|cit28","first-page":"92","article-title":"Bronchiectasis: challenges in diagnosis and management","volume":"1","author":"Lavery","year":"2005","journal-title":"International Journal of Respiratory Care"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0029|cit29","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012514.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Martinez-Garcia","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"647-56","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012514.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"i1-i58","DOI":"10.1136\/thx.2010.142778","article-title":"British Thoracic Society Bronchiectasis Non-CF Guideline Group. British Thoracic Society guideline for non CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD012514.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0037|cit37","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Ringshausen FC de Roux A Diel R Hohmann D Welte T Rademacher J Bronchiectasis in Germany: a population-based estimation of disease prevalence European Respiratory Journal 2015 1805 7","DOI":"10.1183\/13993003.00954-2015"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","article-title":"Trends in bronchiectasis mortality in England and Wales","volume":"104","author":"Roberts","year":"2010","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"177-84","DOI":"10.1159\/000366000","article-title":"Aerosolized antibiotics for non-cystic fibrosis bronchiectasis","volume":"88","author":"Rubin","year":"2014","journal-title":"Respiration"},{"issue":"4","key":"10.1002\/14651858.CD012514.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD012514.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD012514.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \"too high\" for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Paediatrics"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clinical Pulmonary Medicine"},{"key":"10.1002\/14651858.CD012514.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD012514.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"321-9","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"issue":"1","key":"10.1002\/14651858.CD012514.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012514","article-title":"Dual antibiotics for non-cystic fibrosis bronchiectasis","author":"Felix","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012514.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T23:36:22Z","timestamp":1639956982000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012514.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012514.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]}}}